Home  >  Products  >  TNFRSF13B (tumor necrosis factor receptor superfamily, member 13B ) Blocking Peptide (the N terminal of TNFRSF13B)(100ug)
TNFRSF13B (tumor necrosis factor receptor superfamily, member 13B ) Blocking Peptide (the N terminal of TNFRSF13B)(100ug)

TNFRSF13B (tumor necrosis factor receptor superfamily, member 13B ) Blocking Peptide (the N terminal of TNFRSF13B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TNFRSF13B Antibody (ARP63655_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63655
Size: 100ug
Weight: 32kDa
Gene: 23495
Format: Lyophilized powder
Target: The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17.
Alternative names: CD267; CVID; FLJ39942; MGC133214; MGC39952; TACI; TNFRSF14B
See Full Product Listings >